Hanmi releases simvastin CR tablets

Published: 2009-02-04 06:57:00
Updated: 2009-02-04 06:57:00
Hanmi Pharm said on February 2 that it has launched its new simvastin controlled-release (CR) 20 mg tablets, followed by its best-selling second simvastin series.

According to the company, the advantages of once-daily simvastin CR tablets are that they can often be taken less frequently than i...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.